Overview

Study on the Use of Low Dose Ketamine After Gastric Bypass and Gastrectomy

Status:
Completed
Trial end date:
2017-04-13
Target enrollment:
Participant gender:
Summary
This is a randomized, double-blind, placebo-controlled, two-arm parallel, single-center study. One hundred subjects (50 in each arm) will be enrolled. Subjects, between the ages 18 and 65, undergoing laparoscopic gastric bypass or sleeve gastrectomy will be recruited and consented during the preadmission visit prior to surgery.
Phase:
Phase 2/Phase 3
Details
Lead Sponsor:
New York University School of Medicine
NYU Langone Health
Treatments:
Ketamine